 DUBLIN, Ohio--BUSINESS WIRE--Navidea Biopharmaceuticals, Inc. NYSE American: NAVB Navidea or the Company, a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced it will host a conference call and webcast on Tuesday, May 11 2021 at 5:00 p.m. EDT to discuss financial results and corporate developments for the first quarter ended March 31, 2021. Jed Latkin, Chief Executive Officer, Dr. Michael Rosol, Chief Medical Officer, and 